The drug "Emoxipin". Reviews, instructions

The drug "Emoksipin" is an antioxidant. This drug prevents the peroxidation of cell membrane lipids . It produces antihypoxic (increases the resistance of tissues to lack of oxygen), angioprotective (strengthens blood vessels) and antiaggregational (does not allow the adhesion of platelets) effect.

The drug "Emoxipin", reviews of which are mostly positive, was originally proposed for use in ophthalmology for the therapy of intraocular hemorrhage; Retinopathy (diabetic) - non-inflammatory lesion of the ocular retina caused by an increase in the sugar content in the blood; Chorioretinal central dystrophy - an ailment that develops as a result of brain diseases; Thrombosis (formation of blood clots) of branches and central vein of the retina; Hemorrhages after injuries; Shortsightedness (myopia). However, at present, this medicine is widely used to eliminate other diseases that are accompanied by hypoxia and activation of lipid peroxidation - myocardial infarction, acute blood loss, glaucoma and other diseases caused by unsatisfactory tissue supply with oxygen or inadequate assimilation.

The drug "Emoxipin" (reviews unanimously) effectively copes with the protection of the mesh membrane of the organs of vision from the effects of high-intensity light - laser and sunburn. Also, the drug is successfully used for recovery after surgery in patients with glaucoma, followed by a detachment of the choroid (vascular membrane).

Drops of "Emoxipin". Instructions

Methods of using the drug are as follows:

- for the eyeball (retrobulbarno);

- the space surrounding the eyeball (parabulbarno);

- under the outer shell of the eyes (subconjunctivally).

A retrobulbar drug is injected at half a milliliter of a 1% solution once a day for ten to fifteen days. Parabulbarno or subconjunctival drug is installed on 0.2-0.5 milliliters of a 1% solution of 1 rub. / Day ten to thirty days.

If necessary, treatment can be conducted up to three times a year. It is noted that, for protective purposes, during laser coagulation, the drug is installed for an eyeball one hour before the procedure (half a milliliter of a 1% solution). Next, the drug is used for 2-10 days in a similar way.

When cauterizing tumors, the drug is administered before the destructive and limiting coagulation according to the same scheme. It is noted that the treatment with the pharmaceutical drug "Emoxipin" (the description of the action of which was given above) should be carried out under the control of the indicators of blood coagulability.

As a solution, the drug is administered intravenously (drip) in the acute period of myocardial infarction (ten micrograms per kilogram of the patient's weight per day) for five days, after which intramuscularly one milligram per kilogram for two more weeks. As a result of the use of the drug "Emoxipin", reviews confirm that the area of necrosis (necrosis of tissues) is decreasing and recovery processes are accelerating.

For the treatment of true eczema, the agent is administered intramuscularly twice a day (one milliliter of a 1% solution). The course of treatment - at least two weeks.

It should be taken into account that mixing of the indicated and other therapeutic solutions is unacceptable.

The drug "Emoxipin" (reviews of which confirm its effectiveness) can cause a burning sensation, discomfort, redness, and also cause the compaction of tissues near the eyeball.

The installation of corticosteroids helps to eliminate unwanted effects.